Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of GENFLOW BIOSCIENCES PLC
No Price
Closing Price XLON 28.04.2026:
2,74 GBX
28.04.2026 15:06
Current Prices from GENFLOW BIOSCIENCES PLC
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
London
GENF.L
GBX
28.04.2026 15:06
2,74 GBX
0,24 GBX
+9,60 %
Share Float & Liquidity
Free Float39,07 %
Shares Float209,29 M
Shares Outstanding535,65 M
Company Profile for GENFLOW BIOSCIENCES PLC Share
Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. The company was incorporated in 2021 and is headquartered in London, the United Kingdom.
